JUNE Medical Launches Semi-Blunt Hooks for the Galaxy II® Retractor

JUNE Medical, an international surgical device company with a reputation for innovation, has just launched 5 mm Semi-Blunt hooks for its award-winning Galaxy II® range of surgical retractors. Offering the perfect balance between the existing razor-sharp and precise Sharp hook and the more forgiving Blunt hook, the new atraumatic Semi-Blunt combines a reliable hold with less sharp penetration, staying where it is placed and allowing higher loads under more tension.

The 5 mm Semi-Blunt hooks minimize tissue trauma while maintaining a strong grip, making them ideal for challenging procedures like fistulae repair, excision of urethral diverticulum, and mesh removal surgery, where a good exposure is difficult to attain without interruption. These new hooks are both convenient and time-efficient for surgeons, as well as offering trainees improved visibility to learn surgical steps – a win-win!

Prof. Hashim Hashim, Director of the Urodynamics Unit at the Bristol Urological Institute at Southmead Hospital, commented: “For many procedures, the Blunt hooks simply can’t adequately hold onto tissues, while the Sharp ones can cause damage, as well as risking injury to the surgeon. We, therefore, needed an option that can grip tissue better without traumatizing it and, equally importantly, not cause a sharp injury to the surgeon. JUNE has listened to the surgeons and catered for that.”

Angela Spang, CEO of JUNE Medical, added: “The new Semi-Blunt hook brings together the best of both worlds – a strong, elastic hold and reduced tissue trauma. We are introducing this new hook based on feedback from the esteemed surgeons who routinely use our Galaxy II® retractors with Sharp and Blunt hooks. In a discipline like surgery, there is no room for compromise, and we aim to deliver the best tools for the surgeons and the patients.”

Find out more about the SEMI BLUNT Galaxy II® hooks visit here.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.